NN111: “A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial”
Ka-Ho Wong, Gregory Scott Day, James C. Torner, Merit Cudkowicz, Christopher S. Coffey, Hyun Joo Sophie Cho, Ursula Utz, David B. Clifford, Eliezer Katz, John Ratchford, Susan Flavin, Annalisa Dialino-Felix, Lisa M. Dill, Cornelia Kamp, Eric C. Klawiter, John Robinson Singleton, Janel Fedler, Elizabeth A. Klingner, Dixie Ecklund, David Klements, Michele Costigan, Erin Steinhart, Brenda Pearson, Christina Desir, Josep O. Dalmau, Maarten J. Titulaer, and Stacey L. Clardy
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial